Skip to main content

FTC appeals ruling in case challenging Illumina's acquisition of GRAIL

The Federal Trade Commission on Friday filed a notice of appeal in its case challenging Illumina's $7.1 billion acquisition of cancer detection company GRAIL.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.